Report: Cost of dementia to exceed $604 billion, number of cases to double every 20 years

Report: Global cost of dementia is soaring

HEALTHBEAT: Somewhat ignored Alzheimer’s tangles get new attention, offer clue to worsening

Alzheimer’s brain tangles offer clue to worsening

Summary Box: Eli Lilly halts development of potential Alzheimer’s drug in late-stage testing

Alzheimers the Journey

FDA panel of advisers backs GlaxoSmithKline seizure drug, despite side effects

Epilepsy Foundation of

Tony Judt, historian who challenged conventions and author of ‘Postwar,’ dies at age 62

Tony Judt, author of ‘Postwar,’ dies at 62

Advances in finding Alzheimer’s disease show the need for drugs to stop or slow its course

Dementia Algorithm

British doctors say there could be twice as many cases of Huntington’s disease as once thought

huntingtons hero 2

Inspirational high school coach Charlie Wedemeyer dies at 64

pneumonia

For Davis Phinney, it’s the little victories that matter to Parkinson’s sufferers like him

parkinsons live (53778

Study suggests pesticides in foods may contribute to attention-deficit disorder in kids

Research links pesticides with ADHD in children

Deadly strain of meningitis his Burkina Faso

Antibiotics

Colombian presidential contender Antanas Mockus has Parkinson’s disease, campaign continues

Ben Parkinson
more images

South Carolina’s Spratt announces re-election bid, says has early stage Parkinson’s disease

Ben Parkinson
more images

Actor Michael J. Fox named honorary doctor in Sweden for Parkinson’s awareness work

Parkinson's patients get

Southern Calif. jury decides Botox-maker Allergan not responsible for 7-year-old’s death

pneumonia
more images

HEALTHBEAT: Study will put to test growing evidence linking high blood pressure to dementia

dementia

MedGenesis gives Amgen unspecified equity stake for rights to potential treatment

030125parkinsons492

HEALTHBEAT: Toddler’s rebound from rare metabolic disease highlights quest for newborn testing

us for CDC's Cerebral Palsy
more images

Muhammad Ali attends opening of expanded Parkinson’s institute in Phoenix named after him

030125parkinsons492

Analysis finds reports on Pfizer epilepsy drug studies misleading; drugmaker disputes review

7th Canadian Epilepsy
more images

White House adviser and his wife push for better treatment of epilepsy for daughter and others

have epilepsy for the past

Avanir Pharma says higher dose of Zenvia reduced number of emotional outbursts tied to disease

Avanir posts mixed late stage Zenvia study results

ALISO VIEJO, Calif. — Avanir Pharmaceuticals Inc. on Friday reported mixed results for its drug candidate Zenvia, which is intended to reduce involuntary emotional outbursts in patients with neurological disorders.

Shares of Acorda Therapeutics dive after FDA questions experimental multiple sclerosis drug

Acorda shares plunge on negative FDA review

WASHINGTON — Shares of Acorda Therapeutics plummeted Friday after the Food and Drug Administration issued a negative opinion that questioned the safety and effectiveness of the company’s multiple sclerosis drug.

Report finds Alzheimer’s, dementia afflict more than 35 million worldwide and rising rapidly

Report: 35 million-plus worldwide have dementia

WASHINGTON — More than 35 million people around the world are living with Alzheimer’s disease or other types of dementia, says the most in-depth attempt yet to assess the brain-destroying illness — and it’s an ominous forecast as the population grays.

Acadia Pharmaceuticals shares plunge as Parkinson’s disease drug fails late-stage study

Acadia shares fall on failed Parkinson’s study

NEW YORK — Shares of Acadia Pharmaceuticals Inc. plunged Tuesday after the company said its drug candidate pimavanserin failed to meet key treatment goals in a late-stage study focusing on patients with Parkinson’s disease psychosis.

HEALTHBEAT: Amid flu flurry, don’t forget teen shots against different threat _ meningitis

Rare but deadly meningitis: Don’t forget kid shots

WASHINGTON — Fever, chills, vomiting: It starts like a stomach bug or the flu. But bacterial meningitis can go on to kill terrifyingly fast — one of the few infections in the U.S. where someone can feel fine in the morning and be dead by night. And prime targets are tweens, teens and college freshmen.

Protected by Comment Guard Pro